ASO Author Reflections: Old Truths, New Data: Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Requires Continued Surveillance
PASTIntraductal papillary mucinous neoplasms (IPMNs) are recognized precursors to pancreatic cancer, with invasive subtypes historically categorized as tubular, colloid, or oncocytic. 1Among these, intraductal oncocytic papillary neoplasm (IOPN)-derived pancreatic cancer is recognized as a distinct entity with unique histologic and genetic features and has long been thought to carry a more favorable prognosis.However, due to its low incidence, comprehensive data on its clinical behavior and long-term outcomes remain limited.
Authors
- Greg D. Sacks (ORCID: https://orcid.org/0000-0003-1205-6477)
- Joseph R. Habib (ORCID: https://orcid.org/0000-0003-3445-2278)
- Ammar A. Javed (ORCID: https://orcid.org/0000-0002-5463-5250)
- C Salinas (ORCID: https://orcid.org/0000-0002-6279-3689)
Institutions
- University of Oxford (GB)
- Cancer Genomics Centre (NL)
- New York University (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1245/s10434-025-18007-z
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00